Vitamin D and Parkinson’s disease
Objective: to study the correlation between vitamin D levels (deficiency) and clinical presentations in patients with Parkinson’s disease Background: previous studies throughout the world have…Does neurodegeneration of the noradrenergic locus coeruleus follow a spatial gradient in Parkinson’s disease?
Objective: To map degeneration of the locus coeruleus in Parkinson’s disease in-vivo using ultra-high field MRI. Background: Parkinson’s disease (PD) causes degeneration of dopaminergic neurons…Functional Constipation in Parkinson’s Disease
Objective: To analyze and compare the Rome IV Criteria of Functional Constipation between PD and HC, with that followed by MDS-NMS, intended for determining clinical…Constipation in Parkinson’s disease: Clinical and Neurosonographic Study
Objective: We aimed to study the possible impact of constipation on motor, non-motor, depressive symptoms, cognitive functions and neurosonographic findings in idiopathic Parkinson's disease (PD)…Increased non-motor impairment in Parkinson’s disease with REM-Sleep behaviour disorder; cross-sectional analysis in Luxembourg Parkinson’s Study
Objective: To identify specific differences in motor and non-motor profile in Parkinson’s disease (PD) with or without probable REM-Sleep behaviour disorder (pRBD) based on the…The impact of fatigue and pain on functional mobility, fear of falling, and falls in Individuals with Parkinson’s disease
Objective: This is a cross-sectional pilot study aiming to examine: (1) the relationship of fatigue and pain with functional mobility, fear of falling (FOF), and falls in individuals with Parkinson's disease (PD), (2) differences in fatigue and pain between PD fallers and non-fallers, and (3) distinguishing…Predictors of Clinically Significant Quality of Life Impairment in Parkinson´s Disease. Results from the COPPADIS Cohort at 2 Years Follow-up.
Objective: The aim of the present study was to identify predictors of clinically significant quality of life (QoL) impairment in Parkinson´s disease (PD) patients from…Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease; role for cholinergic transmission?
Objective: To understand to what extent an early cochlear dysfunction may represent an additional non-motor signature of Parkinson’s disease (PD) patients. Further, whether it may…Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.
Objective: The aim of the present study was to identify predictors of non-motor symptoms burden non-progression (NMSB-NP) in PD patients from a Spanish cohort [1,2].…Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms including Sleep: Results from a Meta-Analysis with 24-month follow-up
Objective: To evaluate the impact of levodopa-carbidopa intestinal gel (LCIG) on dyskinesia, sleep, and other non-motor symptoms over 24 months after initiation. Background: Complications of…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 51
- Next Page »